Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

umbilical cord blood-derived MAK immune cells

A preparation of mixed-activated killer (MAK) immune cells derived from human umbilical cord blood (UCB) cells, with potential cytotoxic activity. Hematopoietic stem cells (HSCs) are isolated followed by ex vivo differentiation and expansion. Upon administration, the UCB-derived MAK immune cells may lyse cancer cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:UCB-derived MAK cells
UCB-derived MAK immune cells
umbilical cord blood-derived mixed-activated killer immune cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search